Alnylam Pharmaceuticals, Inc.

CANADA PENSION PLAN INVESTMENT BOARD ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

258,711

Value ($000)

102,876

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	102,876	0.1%	258,711	12/31/2025
2025 Q3	11/13/2025	62,167	0.0%	136,331	9/30/2025
2025 Q2	8/14/2025	11,583	0.0%	35,520	6/30/2025
2025 Q1	5/15/2025	16,345	0.0%	60,532	3/31/2025
2024 Q4	2/13/2025	40,949	0.0%	174,021	12/31/2024
2024 Q3	11/14/2024	94,846	0.1%	344,858	9/30/2024
2024 Q2	8/12/2024	68,996	0.1%	283,933	6/30/2024
2024 Q1	5/14/2024	40,918	0.0%	273,790	3/31/2024
2023 Q4	2/14/2024	46,512	0.1%	242,998	12/31/2023
2023 Q3	11/9/2023	26,795	0.0%	151,298	9/30/2023
2023 Q2	8/9/2023	31,815	0.0%	167,498	6/30/2023
2023 Q1	5/15/2023	33,894	0.1%	169,198	3/31/2023
2022 Q4	2/14/2023	14,764	0.0%	62,123	12/31/2022
2022 Q3	11/14/2022	14,248	0.0%	71,183	9/30/2022
2022 Q2	8/12/2022	71	0.0%	490	6/30/2022
2022 Q1	5/13/2022	165	0.0%	1,013	3/31/2022
2021 Q4	2/14/2022	9,520	0.0%	56,137	12/31/2021
2021 Q3	11/15/2021	17,236	0.0%	91,288	9/30/2021
2021 Q2	11/16/2021	6,728	0.0%	39,690	6/30/2021
2021 Q1	8/16/2021	16,711	0.0%	118,357	3/31/2021
2020 Q4	2/17/2021	1,329	0.0%	10,225	12/31/2020
2020 Q3	11/12/2020	2,413	0.0%	16,573	9/30/2020
2020 Q2	8/14/2020	10,617	0.0%	71,686	6/30/2020
2020 Q1	5/13/2020	8,117	0.0%	74,572	3/31/2020
2019 Q4	2/14/2020	8,588	0.0%	74,572	12/31/2019